Not applicableWithdrawnNCT02306512What this trial is testingMohs and Immunofluorescence for Malignant Melanoma In SituWho this might be right forLentigo MalignaMelanoma In Situ University of Miami
Not applicableStudy completedNCT03628417What this trial is testingConfirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous MetastasesWho this might be right forCutaneous Melanoma Szeged University 7
Not applicableEnrolling By InvitationNCT06388252What this trial is testingElectrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous MelanomaWho this might be right forCutaneous Malignant Melanoma Institute of Oncology Ljubljana 10
Early research (Phase 1)Ended earlyNCT00492440What this trial is testingInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Cytheris SA 9
Testing effectiveness (Phase 2)Study completedNCT00334776What this trial is testingVaccine Therapy in Treating Patients With Metastatic MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) University of Southern California 6
Not applicableLooking for participantsNCT06887348What this trial is testingAssess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3Who this might be right forMelanomaMetastatic MelanomaAdvanced Solid Tumor+1 more Replimune Inc. 50
Not applicableStudy completedNCT02902822What this trial is testingTele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoWho this might be right forErysipelasImpetigoHerpes Zoster+7 more Centro Studi Gised 461
Early research (Phase 1)Ended earlyNCT00977145What this trial is testingEvaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With MelanomaWho this might be right forMelanoma Craig L Slingluff, Jr 11
Not applicableEnded earlyNCT04688749What this trial is testingUse of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin DamageWho this might be right forMelanoma (Skin)Basal Cell CarcinomaSquamous Cell Carcinoma+5 more Aristotle University Of Thessaloniki 50
Testing effectiveness (Phase 2)Study completedNCT00004135What this trial is testingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) University of Chicago 19
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Not applicableStudy completedNCT01886235What this trial is testingIntravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by SurgeryWho this might be right forRecurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more Roswell Park Cancer Institute 10
Early research (Phase 1)Active Not RecruitingNCT05492682What this trial is testingSTART: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerWho this might be right forMelanoma (Skin)Triple-Negative Breast CancerNon-Small Cell Lung Cancer+5 more Valo Therapeutics Oy 15
Not applicableLooking for participantsNCT03906253What this trial is testingEffectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic NeoplasiaWho this might be right forActinic KeratosesAgingNon-Melanoma Skin Cancer Wright State University 72
Early research (Phase 1)Study completedNCT05169957What this trial is testingHepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)Who this might be right forMelanoma, OcularMelanoma, CutaneousMetastatic Melanoma+2 more University of Michigan Rogel Cancer Center 2
Large-scale testing (Phase 3)Active Not RecruitingNCT06320353What this trial is testingStudy сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin MelanomaWho this might be right forSkin Melanoma R-Pharm 266
Testing effectiveness (Phase 2)WithdrawnNCT04995094What this trial is testingStudy of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable MelanomaWho this might be right forPathologic Stage III Cutaneous Melanoma AJCC v8 HiberCell, Inc.
Testing effectiveness (Phase 2)Study completedNCT00062036What this trial is testingCyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) National Institutes of Health Clinical Center (CC) 33
Not applicableLooking for participantsNCT06008977What this trial is testingExercise to Boost Response to Checkpoint Blockade ImmunotherapyWho this might be right forCutaneous MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma AdventHealth Translational Research Institute 20
Very early researchStudy completedNCT02320305What this trial is testingMART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by SurgeryWho this might be right forStage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin Melanoma+4 more Mayo Clinic 23